Antares Pharma reported $7.2M in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2912M 376M
Abbvie ABBV:US $ 5029M 601M
Adma Biologics ADMA:US $ -14815070 1.62M
Aerie Pharmaceuticals AERI:US $ -33643000 85.38M
Ani Pharmaceuticals ANIP:US $ -19195000 1.8M
Atrion ATRI:US 7.84M 1.64M
Becton, Dickinson and BDX:US $ 805M 105M
Cara Therapeutics CARA:US $ -27911000 5.61M
Cerus CERS:US $ -9848000 2.89M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Endo International Ordinary Shares ENDP:US $ 120.25M 52.02M
Horizon Pharma HZNP:US 196.44M 99.18M
JAZZ PHA JAZZ:US 87.55M 105.43M
Meridian Bioscience VIVO:US $ 36.72M 16.15M
Orasure Technologies OSUR:US $ -16014000 6.68M
Pacira Pharmaceuticals PCRX:US $ 21.73M 24.09M
Pfizer PFE:US $ 9995M 4136M
Revance Therapeutics RVNC:US $ -62221000 617K
Sientra SIEN:US $ -16095000 2.37M
Staar Surgical STAA:US $ 12.11M 4.73M
Supernus Pharmaceuticals SUPN:US $ 1.97M 26.43M
Teva Pharmaceutical TEVA:IT 789M 182M
Teva Pharmaceutical Industries TEVA:US 789M 182M
Utah Medical Products UTMD:US 5.1M 1.21M